Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial Mateos, MV, Cavo, M, Blade, J, Dimopoulos, MA, Suzuki, K, Jakubowiak, A, Knop, S, Doyen, C, Lucio, P, Nagy, Z, Pour, L, Cook, M, Grosicki, S, Crepaldi, A, Liberati, AM, Campbell, Philip, Shelekhova, T, Yoon, SS, Iosava, G, Fujisaki, T, Garg, M, Krevvata, M, Chen, Y, Wang, J, Kudva, A, Ukropec, J, Wroblewski, S, Qi, M, Kobos, R and San-Miguel, J 2020, Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial, The Lancet, vol. 395, no. 10218, pp. 132-141, doi: 10.1016/S0140-6736(19)32956-3. Attached Files Name Description MIMEType Size Downloads Title Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial Author(s) Mateos, MV Cavo, M Blade, J Dimopoulos, MA Suzuki, K Jakubowiak, A Knop, S Doyen, C Lucio, P Nagy, Z Pour, L Cook, M Grosicki, S Crepaldi, A Liberati, AM Campbell, Philip Shelekhova, T Yoon, SS Iosava, G Fujisaki, T Garg, M Krevvata, M Chen, Y Wang, J Kudva, A Ukropec, J Wroblewski, S Qi, M Kobos, R San-Miguel, J Journal name The Lancet Volume number 395 Issue number 10218 Start page 132 End page 141 Total pages 10 Publisher The Lancet Publishing Group Place of publication London, Eng. Publication date 2020-01 ISSN 0140-6736 1474-547X Language eng DOI 10.1016/S0140-6736(19)32956-3 Field of Research 11 Medical and Health Sciences HERDC Research category C1 Refereed article in a scholarly journal Persistent URL http://hdl.handle.net/10536/DRO/DU:30159552 Document type: Journal Article Collections: Faculty of Health School of Medicine Related Links Link Description Connect to published version Go to link with your DU access privileges   Connect to Elements publication management system Go to link with your DU access privileges     Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved. Versions Version Filter Type Mon, 29 Nov 2021, 09:09:13 EST Mon, 29 Nov 2021, 15:04:28 EST Wed, 15 Dec 2021, 05:05:20 EST Thu, 17 Feb 2022, 09:16:33 EST Thu, 17 Feb 2022, 14:39:19 EST Thu, 17 Feb 2022, 14:44:45 EST Thu, 17 Feb 2022, 14:57:01 EST Filtered Full Citation counts:   Cited 0 times in TR Web of Science Cited 161 times in Scopus Search Google Scholar Access Statistics: 10 Abstract Views, 0 File Downloads  -  Detailed Statistics Created: Mon, 29 Nov 2021, 09:09:13 EST